Business Context and Reporting Period
This Form 8-K, dated February 13, 2014, reports the completion of Fluidigm Corporation's acquisition of DVS Sciences, Inc. ("DVS"). The transaction was executed pursuant to a Merger Agreement dated January 28, 2014, resulting in DVS becoming a wholly-owned subsidiary of Fluidigm.
Key Financial Metrics and Transaction Details
The filing details the consideration paid to former DVS stockholders, which includes:
- Cash Consideration: Approximately $125,000,000 (less certain deductions).
- Stock Consideration: Approximately 1,759,007 shares of Fluidigm common stock.
- Escrow Arrangements: $1,000,000 of the cash consideration and 50.3030% of the stock consideration were deposited into escrow to satisfy working capital adjustments and indemnification obligations.
- Financing: The cash portion was financed in part using net proceeds from Fluidigm's public offering of 2.75% Senior Convertible Notes due 2034.
Specific revenue, profit, cash flow, margin, debt, and liquidity metrics for the combined entity are not provided in the text of this filing. Audited financial statements for DVS (years ended Dec 31, 2011 and 2012) and unaudited pro forma combined financial data for Fluidigm are referenced as Exhibits 99.2 and 99.3 but are not included in the narrative text.
Material Changes
The primary material change is the consolidation of DVS into Fluidigm. DVS's wholly-owned Ontario subsidiary remains unaffected by the merger structure. Additionally, DVS stock options and unvested restricted stock were converted into Fluidigm-denominated instruments based on a specified exchange ratio.
Outlook, Risks, and Contingencies
Management issued a press release announcing the completion of the acquisition. The filing includes a Safe Harbor Statement regarding forward-looking statements, highlighting significant risks and uncertainties, including:
- Lack of experience in acquiring and integrating new businesses.
- Risks related to the integration of DVS's operations with Fluidigm's.
- Possibility of failing to realize anticipated revenue or operating expense synergies.
- Potential loss of key employees, customers, or suppliers.
- Intellectual property risks, including maintaining in-licensed rights.
- Market acceptance of products and competition.
Investor Verification Checklist
- Review Exhibit 99.3 for unaudited pro forma condensed combined financial data to understand the immediate financial impact of the acquisition.
- Examine Exhibit 99.2 for DVS's historical financial performance (audited 2011-2012 and unaudited 2013).
- Verify the terms of the 2.75% Senior Convertible Notes due 2034 referenced in the financing section.
- Assess the specific exchange ratio used for converting DVS equity awards into Fluidigm stock.
- Monitor the release of escrowed funds based on working capital adjustments and indemnification claims.